Loomis, Sayles & Company’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Loomis, Sayles & Company’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,265	Closed	-$289K	–	1014
2022 Q3	$289K	Hold	23,265	–	–	﹤0.01%	450
2022 Q2	$456K	Sell	23,265 -20	-0.1%	-$754	﹤0.01%	452
2022 Q1	$608K	Sell	23,285 -50,489	-68%	-$2.11M	﹤0.01%	489
2021 Q4	$2.09M	Buy	73,774 +8,389	+13%	+$404K	﹤0.01%	449
2021 Q3	$2.08M	Buy	65,385 +16,251	+33%	+$846K	﹤0.01%	447
2021 Q2	$1.71M	Buy	+49,134	New	+$2.47M	﹤0.01%	478

Other funds holding ELAT

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Loomis, Sayles & Company's ELAT Position: Q4 2022 in Review

Loomis, Sayles & Company sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q4 2022, closing a stake of 23,265 shares — an estimated $289K sold.

Loomis, Sayles & Company first reported a position in ELAT in Q2 2021 and held it in 6 quarters. The position peaked at $2.09M in Q4 2021. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.

Loomis, Sayles & Company reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q4 2022 after selling out during the quarter.
Loomis, Sayles & Company sold 23,265 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q4 2022, an estimated $289K.
Loomis, Sayles & Company first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q2 2021 and held it in 6 quarters.
Loomis, Sayles & Company's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $2.09M in Q4 2021.
27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.

Based on Loomis, Sayles & Company's 13F filing for Q4 2022, filed 10 Feb 2023.